Manuel Vidal-Sanz

18PUBLICATIONS
33CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Autonomic nervous systemMolecular targetsRadiation therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Mar 11, 2026
Minocycline and bone marrow-derived mononuclear cells as potential therapeutics for hereditary retinal degenerations.

Alba Videla-Ristol, Ana Martínez-Vacas, David García-Bernal

|Feb 13, 2026
Systemic Inflammation Aggravates Retinal Ganglion Cell Vulnerability to Optic Nerve Trauma in Adult Rats.

Giuseppe Rovere, Yolanda Caja-Matas, Beatriz Vidal-Villegas

|Feb 07, 2025
Neuroprotection of retinal ganglion cells by agonism of the beta but not the alpha oestrogen receptor in the axotomized retina of male and female mice.

Kristy T Rodríguez-Ramírez, Caridad Galindo-Romero, Fernando Lucas-Ruiz

|Feb 25, 2023
Comparative Analysis of Retinal Organotypic Cultures and In Vivo Axotomized Retinas.

María José González-Riquelme, Fernando Lucas-Ruiz, Caridad Galindo-Romero

|Aug 20, 2022
Immune recognition of syngeneic, allogeneic and xenogeneic stromal cell transplants in healthy retinas.

María Norte-Muñoz, Alejandro Gallego-Ortega, Fernando Lucas-Ruiz

|May 06, 2022
Intravitreal and subretinal syngeneic bone marrow mononuclear stem cell transplantation improves photoreceptor survival but does not ameliorate retinal function in two rat models of retinal degeneration.

Johnny Di Pierdomenico, Alejandro Gallego-Ortega, Ana Martínez-Vacas

Pageof 3

Frequent Collaborators

8 joint publications

María Paz Villegas-Pérez

7 joint publications

Marta Agudo-Barriuso

6 joint publications

Diego García-Ayuso

6 joint publications

Alejandro Gallego-Ortega